Pontine norepinephrine content after motor cortical ablation in rats

Proceedings of the Western Pharmacology Society

Volumn 48, Issue , 2005, Pages 73-76

  Gonzalez Pina, Rigoberto ^a   Bueno Nava, Antonio ^a   Montes, Sergio ^b   Alfaro Rodriguez, Alfonso ^b   Gonzalez Maciel, Angélica ^b   Reynoso Robles, Rafael ^b   Ayala Guerrero, Fructuoso ^c  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN DAMAGE; CHROMATOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DECAPITATION; HEMISPHERE; HINDLIMB; LOCUS CERULEUS; MALE; MOTOR CORTEX; NONHUMAN; NORADRENALIN BLOOD LEVEL; PONS; RAT; STROKE;

ANIMALS; EFFERENT PATHWAYS; FUNCTIONAL LATERALITY; HINDLIMB; LOCUS COERULEUS; MALE; MOTOR ACTIVITY; MOTOR CORTEX; NOREPINEPHRINE; PONS; RATS; RATS, WISTAR;

EID: 30144433017     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Brailowsky, S., Knight, R.T. and Blood, K. (1986) Brain Res. 362:322-330.
2. Hovda, D.A. and Feeney, D.M. (1984) Brain Res. 298:358-361.
3. Katz, D.I., Alexander, M.P. and Klein, R.B. (1998) Arch. Phys. Med. Rehabil. 79:5488-93.
4. Goldstein, L.B. (2000) Neuropharmacology 39:5:852-859.
5. Sutton R.L., Hovda, D.A., Chen, M.J. and Feeney, D.M. (2000) Neural Plast. 7:1-2:109-125.
6. Boyeson, M.G. and Feeney, D.M. (1990) Pharmacol. Biochem. Behav. 35:3497-501.
7. Kikuchi, K., Nishino, K. and Ohyu, H. (2000) Brain Res. 860:130-135.
8. Boyeson, M.G., Krobert, K.A., Grade, C.M. and Scherer, P.J. (1992) Pharmachol. Biochem. Behav. 43:771-777.
9. Gonzalez-Pina, R., Bueno-Nava, A., Escalante-Membrillo, C., Montes, S., Gonzalez-Maciel, A. and Ayala-Guerrero, F. (2003) Res. Neurol. Neurosc. 21:5-6:219-220.
10. Krobert, K.A., Sutton, R.L. and Feeney, D.M. (1994) J. Neurochem. 62:2233-2240.
11. Berridge, C.W. and Waterhouse, B.D. (2003) Brain Res. Rev. 42:33-84.
12. Aston-Jones, G. Rajkowski, J., Kubiak P. and Alexinsky, T. (1994) J. Neurosci. 14:4467-4480.
13. Goldstein, L.B. and Bullman, S. (1997) Pharmacol. Biochem. Behav. 58:1151-1157.
14. Sutton, R.L. and Feeney, D.M. (1992) Restor. Neurol. Neurosci. 4:1-11.
15. Dunn-Meynell, A.A., Yarlagadda, Y. and Levin, B.E. (1997) J. Neurotrauma. 14:43-52.
16. Waterhouse, B.D., Lin, C.S., Burne, R.A. and Woodward, D.J. (1983) J. Comp. Neurol. 217:418-431.
17. Steindler, D.A. (1981) Brain Res. 223:367-373.
18. Hruska, R.E., Kennedym S. and Silbergeldm, E.K. (1979) Life Sciences 25:171-180.
19. Hall, R.D. and Lindholm, E.P. (1974) Brain Res. 66:23-38.
20. Paxinos, G. and Watson, C. (1982) Academic Press. Australia.
21. Serteser, M., Ösben, T., Gümüslü, S., Balkan, S. and Balkan, E. (2001) Acta Neurol. Scand. 103:43-48.
22. Hobson, J.A. and McCarley, R.W. (1977) Am. J. Psychiatry 134(12):1335-1348.
23. Room, P., Postema, F. and Korf, J. (1981) Brain Res. 221:219-230